Home > Balance Sheet > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr₹4,611 Cr

What is the latest Net Current Assets ratio of GLAND PHARMA ?

The latest Net Current Assets ratio of GLAND PHARMA is ₹5,218 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹5,218 Cr
Mar2024₹4,247 Cr
Mar2023₹6,172 Cr
Mar2022₹5,270 Cr
Mar2021₹4,611 Cr

How is Net Current Assets of GLAND PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹5,218 Cr
22.87
Mar2024 ₹4,247 Cr
-31.19
Mar2023 ₹6,172 Cr
17.11
Mar2022 ₹5,270 Cr
14.29
Mar2021 ₹4,611 Cr -

Compare Net Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹40,598.3 Cr 3.7% 10.2% 36.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.7%

10.2%

36.4%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses